<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02652832</url>
  </required_header>
  <id_info>
    <org_study_id>CSR B04</org_study_id>
    <nct_id>NCT02652832</nct_id>
  </id_info>
  <brief_title>Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels</brief_title>
  <acronym>Plasti-Stim</acronym>
  <official_title>Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital le Vinatier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital le Vinatier</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the effects of non invasive brain stimulation - NIBS
      - techniques (Electroconvulsivotherapy - ECT, transcranial Direct Current Stimulation - tDCS,
      repetitive transcranial magnetic stimulation - rTMS) on serum Brain Derived Neurotrophic
      factor (BDNF) levels in patients with depression and schizophrenia. Four blood samples will
      be collected in each participants, one before the NIBS sessions, and 3 after the completion
      of NIBS protocols: one immediately after the end of the NIBS sessions, a second one week
      after and a last one month after. Two blood samples separated by one month will also be
      collected in a a group of healthy volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The hypothesis is that NIBS will modulate BDNF levels and that the modification in serum BDNF
      levels will be correlated with clinical improvements in the sample of patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2010</start_date>
  <completion_date type="Anticipated">September 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 28, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum BDNF levels</measure>
    <time_frame>from baseline to one month</time_frame>
  </primary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Depression</condition>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Depression Electroconvulsive therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>40 patients with major depression receiving a mean of 12 sessions of Electroconvulsive therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Depression active repetitive transcranial magnetic stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>40 patients with major depression receiving a mean 4 weeks of 1 Hz repetitive transcranial magnetic stimulation applied over the right dorsolateral prefrontal cortex - DLPFC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Depression sham repetitive transcranial magnetic stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>40 patients with major depression receiving a mean 4 weeks of sham 1 Hz repetitive transcranial magnetic stimulation applied over the right dorsolateral prefrontal cortex - DLPFC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Schizophrenia active transcranial magnetic stimulati</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>40 patients with schizophrenia and predominant negative symptoms receiving 20 sessions of intermittent theta burst simulation (iTBS) applied over the left dorsolateral prefrontal cortex - DLPFC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Schizophrenia sham transcranial magnetic stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>patients with schizophrenia and predominant negative symptoms receiving 20 sessions of sham intermittent theta burst simulation (iTBS) applied over the left dorsolateral prefrontal cortex - DLPFC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Schizophrenia active transcranial Direct Current Stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>40 patients with schizophrenia and auditory verbal hallucinations receiving 10 sessions of transcranial Direct current stimulation (tDCS) applied with the anode over the left dorsolateral prefrontal cortex - DLPFC- and the cathode over the left temporoparietal junction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Schizophrenia sham transcranial Direct Current Stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>40 patients with schizophrenia and auditory verbal hallucinations receiving 10 sessions of sham transcranial Direct current stimulation (tDCS) applied with the anode over the left dorsolateral prefrontal cortex - DLPFC- and the cathode over the left temporoparietal junction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>80 healthy volunteers receiving no stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>non invasive brain stimulation</intervention_name>
    <description>non invasive brain stimulation</description>
    <arm_group_label>Depression Electroconvulsive therapy</arm_group_label>
    <arm_group_label>Depression active repetitive transcranial magnetic stimulation</arm_group_label>
    <arm_group_label>Depression sham repetitive transcranial magnetic stimulation</arm_group_label>
    <arm_group_label>Schizophrenia active transcranial magnetic stimulati</arm_group_label>
    <arm_group_label>Schizophrenia sham transcranial magnetic stimulation</arm_group_label>
    <arm_group_label>Schizophrenia active transcranial Direct Current Stimulation</arm_group_label>
    <arm_group_label>Schizophrenia sham transcranial Direct Current Stimulation</arm_group_label>
    <other_name>rTMS</other_name>
    <other_name>tDCS</other_name>
    <other_name>ECT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  in the depression group: DSM IV criteria of MDD; HDRS17&gt; 22; stage 2 of resistance;
             received rTMS or ECT

          -  in the schizophrenia group DSM IV criteria of schizophrenia; pharmaco-resistance of
             symptoms (either negative symptoms or auditory verbal hallucination); received rTMS or
             tDCS

          -  in the healthy volunteers group : to not have axis I of DSM IV diagnosis; no siblings
             with axis I DSM IV diagnosis

        Exclusion Criteria:

          -  less than 18 years old

          -  pregnancy

          -  received benzodiazepine

        In the depression and schizophrenia group:

          -  bipolar disorder

          -  other axis I of DSM IV diagnosis (excluding for Tobacco use disorder)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>jerome brunelin, PhD</last_name>
    <role>Study Director</role>
    <affiliation>CH le vinatier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>lydie sartelet</last_name>
    <phone>+33437915531</phone>
    <email>lydie.sartelet@ch-le-vinatier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopital Le vinatier</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>emmanuel poulet, MD, PhD</last_name>
      <phone>33437915565</phone>
    </contact>
    <investigator>
      <last_name>emmanuel poulet, md, phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>frederic haesebaert, md, phd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 19, 2015</study_first_submitted>
  <study_first_submitted_qc>January 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2016</study_first_posted>
  <last_update_submitted>April 24, 2018</last_update_submitted>
  <last_update_submitted_qc>April 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

